53
Participants
Start Date
October 14, 2021
Primary Completion Date
August 10, 2022
Study Completion Date
August 10, 2022
Placebo
Placebo infusion will be administered intravenously.
Nipocalimab
Nipocalimab infusions will be administered intravenously.
Hosp Univ A Coruna, A Coruña
Hosp. Clinico Univ. de Santiago, Santiago de Compostela
Hamburger Rheuma Forschungszentrum II, Hamburg
DJL Clinical Research, PLLC, Charlotte
Low Country Rheumatology PA, Summerville
Hosp. Do Meixoeiro, Vigo
West Tennessee Research Institute, Jackson
Rheumazentrum Ratingen, Ratingen
Hosp. Virgen Macarena, Seville
STAT Research, Inc., Vandalia
Hosp. Univ. de Basurto, Bilbao
Southwest Rheumatology Research LLC, Mesquite
Accurate Clinical Research, Inc., Houston
Arizona Arthritis & Rheumatology Research, PLLC, Mesa
Arizona Arthritis & Rheumatology Associates PC, Glendale
Arizona Arthritis & Rheumatology Research, PLLC, Tucson
Inland Rheumatology Clinical Trials, Inc., Upland
Arthritis Care and Research Center Inc.: Smitha Reddy, MD, Poway
TriWest Research Associates, LLC, San Diego
Desert Medical Advances, Palm Desert
Szpital Uniwersytecki nr 2 im dr Jana Biziela w Bydgoszczy, Bydgoszcz
NZOZ Lecznica Mak-Med sc, Nadarzyn
Prywatna Praktyka Lekarska Prof Um Dr Hab Med Pawel Hrycaj, Poznan
Centrum Medyczne AMED Targowek, Warsaw
Western General Hospital, Edinburgh
Kings College Hospital NHS Trust, London
North Tyneside General Hospital, Newcastle
Haywood Hospital, Stoke-on-Trent
Janssen Research & Development, LLC
INDUSTRY